Donald Zakrowski - Eli Lilly Chief Fin
| LILY34 Stock | BRL 165.04 7.19 4.55% |
Insider
Donald Zakrowski is Chief Fin of Eli Lilly and
| Phone | 317 276 2000 |
| Web | https://www.lilly.com |
Donald Zakrowski Latest Insider Activity
Tracking and analyzing the buying and selling activities of Donald Zakrowski against Eli Lilly stock is an integral part of due diligence when investing in Eli Lilly. Donald Zakrowski insider activity provides valuable insight into whether Eli Lilly is net buyers or sellers over its current business cycle. Note, Eli Lilly insiders must abide by specific rules, including filing SEC forms every time they buy or sell Eli Lilly'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Donald Zakrowski over a year ago Payment of 2142 shares by Donald Zakrowski of Eli Lilly subject to Rule 16b-3 | ||
Donald Zakrowski over a year ago Sale by Donald Zakrowski of 670 shares of Eli Lilly |
Eli Lilly Management Efficiency
The company has return on total asset (ROA) of 0.1148 % which means that it generated a profit of $0.1148 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.6464 %, meaning that it generated $0.6464 on every $100 dollars invested by stockholders. Eli Lilly's management efficiency ratios could be used to measure how well Eli Lilly manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Sundeep Jain | Uber Technologies | N/A | |
| Farhan Ahmad | Micron Technology | N/A | |
| Balaji CFA | Uber Technologies | N/A | |
| Jill Hazelbaker | Uber Technologies | 41 | |
| Garrett Camp | Uber Technologies | 44 | |
| Manish Bhatia | Micron Technology | 51 | |
| Nelson Chai | Uber Technologies | 57 | |
| Andre Beaudry | Metalurgica Gerdau SA | 64 | |
| Anand Bahl | Micron Technology | N/A | |
| Andr Hofmeister | Metalurgica Gerdau SA | N/A | |
| Sumit Sadana | Micron Technology | 54 | |
| Nestor Mundstock | Metalurgica Gerdau SA | 71 | |
| Claudia Ramirez | Metalurgica Gerdau SA | 43 | |
| Scott Schools | Uber Technologies | N/A | |
| Rafael Japur | Metalurgica Gerdau SA | 41 | |
| Scott DeBoer | Micron Technology | 57 | |
| Manoel Filho | Metalurgica Gerdau SA | 66 | |
| Dara Khosrowshahi | Uber Technologies | 53 | |
| Mark Murphy | Micron Technology | 55 | |
| Nikki Krishnamurthy | Uber Technologies | 51 | |
| Michael Bokan | Micron Technology | 62 | |
Management Performance
| Return On Equity | 0.65 | |||
| Return On Asset | 0.11 |
Eli Lilly Leadership Team
Elected by the shareholders, the Eli Lilly's board of directors comprises two types of representatives: Eli Lilly inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Eli. The board's role is to monitor Eli Lilly's management team and ensure that shareholders' interests are well served. Eli Lilly's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Eli Lilly's outside directors are responsible for providing unbiased perspectives on the board's policies.
| David Ricks, Senior Vice President and Presidentident - Lilly Bio-Medicines | ||
| Alonzo Weems, VP Officer | ||
| Jacob Naarden, CEO VP | ||
| Diogo Rau, VP Officer | ||
| Donald Zakrowski, Chief Fin | ||
| Anat Ashkenazi, VP CFO | ||
| Leigh Pusey, Senior Vice President - Corporate Affairs and Communications | ||
| Martin MIBS, VP Projects | ||
| Anat JD, Gen VP |
Eli Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Eli Lilly a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.65 | |||
| Return On Asset | 0.11 | |||
| Profit Margin | 0.22 % | |||
| Operating Margin | 0.29 % | |||
| Current Valuation | 1.91 T | |||
| Shares Outstanding | 28.51 B | |||
| Price To Earning | 41.09 X | |||
| Price To Book | 34.13 X | |||
| Price To Sales | 60.93 X | |||
| Revenue | 28.54 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Additional Information and Resources on Investing in Eli Stock
When determining whether Eli Lilly offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Eli Lilly's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Eli Lilly And Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Eli Lilly And Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Eli Lilly and. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.